INDICATION: Prostate cancer...
BCIQ Company Profiles
University of Texas MD Anderson Cancer Center
BCIQ Target Profiles
Cytotoxic T-lymphocyte associated protein 4 (CTLA-4) (CTLA4) (CD152)
Polycomb repressive complex 1 (PRC1)
Programmed cell death 1 (PD-1) (PDCD1) (CD279)
Ring finger protein 2 (RNF2)